Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject
US9751924B2 · kind B2 · utility
32Cited by
56References
113Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 2015 |
| Grant date | Sep 5, 2017 |
| Priority date | — |
| Expiry date | Dec 29, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/66
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for and uses in reducing glucose levels in subjects in need thereof with variants and fusions of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.